title: How to improve results for second renal allografts.
authors.affiliation: University of California, San Francisco.
authors.forename: J S
authors.initials: JS
authors.lastname: Melzer
authors.forename: R M
authors.initials: RM
authors.lastname: Husing
authors.forename: N J
authors.initials: NJ
authors.lastname: Feduska
authors.forename: S J
authors.initials: SJ
authors.lastname: Tomlanovich
authors.forename: F
authors.initials: F
authors.lastname: Vincenti
authors.forename: W J
authors.initials: WJ
authors.lastname: Amend
authors.forename: M
authors.initials: M
authors.lastname: Garovoy
authors.forename: C
authors.initials: C
authors.lastname: Lou
authors.forename: O
authors.initials: O
authors.lastname: Salvatierra
mesh_terms: D003404:Creatinine / Q000097:blood; D003602:Cytotoxicity, Immunologic; D004334:Drug Administration Schedule; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007518:Isoantibodies / Q000276:immunology; D016030:Kidney Transplantation; D012008:Recurrence; D012307:Risk Factors
chemical_list: D007518:Isoantibodies; D003404:Creatinine